WINTON GROUP Ltd Has $1.45 Million Stake in Monsanto Company (MON)

WINTON GROUP Ltd lifted its holdings in shares of Monsanto Company (NYSE:MON) by 28.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,221 shares of the basic materials company’s stock after buying an additional 2,738 shares during the period. WINTON GROUP Ltd’s holdings in Monsanto were worth $1,446,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Pinnacle Financial Partners Inc. purchased a new position in shares of Monsanto during the 2nd quarter worth approximately $114,000. Bruderman Asset Management LLC purchased a new position in shares of Monsanto during the 2nd quarter worth approximately $116,000. Tower Research Capital LLC TRC raised its stake in shares of Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after buying an additional 750 shares in the last quarter. Armbruster Capital Management Inc. raised its stake in shares of Monsanto by 12.2% during the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after buying an additional 125 shares in the last quarter. Finally, JNBA Financial Advisors raised its stake in shares of Monsanto by 3.9% during the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after buying an additional 45 shares in the last quarter. 74.77% of the stock is owned by institutional investors and hedge funds.

WARNING: This report was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://ledgergazette.com/2017/10/19/winton-group-ltd-has-1-45-million-stake-in-monsanto-company-mon.html.

In related news, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Nicole M. Ringenberg sold 7,890 shares of the firm’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the transaction, the vice president now directly owns 38,600 shares of the company’s stock, valued at approximately $4,718,850. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 44,916 shares of company stock worth $5,404,894. Insiders own 0.79% of the company’s stock.

Monsanto Company (NYSE:MON) opened at 121.97 on Thursday. The firm has a 50-day moving average price of $119.21 and a 200-day moving average price of $117.49. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $122.80. The firm has a market capitalization of $53.61 billion, a P/E ratio of 23.97 and a beta of 1.07.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.07 earnings per share. Equities analysts forecast that Monsanto Company will post $5.70 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.77%. Monsanto’s payout ratio is presently 42.27%.

A number of equities analysts have recently issued reports on MON shares. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a research note on Wednesday, July 12th. Wells Fargo & Company increased their target price on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research note on Tuesday, October 10th. UBS AG downgraded Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price for the company. in a research note on Friday, August 18th. Finally, BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Eleven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the st

Other hedge funds have also modified their holdings of the company. Pinnacle Financial Partners Inc. purchased a new position in shares of Monsanto during the 2nd quarter worth approximately $114,000. Bruderman Asset Management LLC purchased a new position in shares of Monsanto during the 2nd quarter worth approximately $116,000. Tower Research Capital LLC TRC raised its stake in shares of Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after buying an additional 750 shares in the last quarter. Armbruster Capital Management Inc. raised its stake in shares of Monsanto by 12.2% during the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after buying an additional 125 shares in the last quarter. Finally, JNBA Financial Advisors raised its stake in shares of Monsanto by 3.9% during the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after buying an additional 45 shares in the last quarter. 74.77% of the stock is owned by institutional investors and hedge funds.

WARNING: This report was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://ledgergazette.com/2017/10/19/winton-group-ltd-has-1-45-million-stake-in-monsanto-company-mon.html.

In related news, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Nicole M. Ringenberg sold 7,890 shares of the firm’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the transaction, the vice president now directly owns 38,600 shares of the company’s stock, valued at approximately $4,718,850. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 44,916 shares of company stock worth $5,404,894. Insiders own 0.79% of the company’s stock.

Monsanto Company (NYSE:MON) opened at 121.97 on Thursday. The firm has a 50-day moving average price of $119.21 and a 200-day moving average price of $117.49. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $122.80. The firm has a market capitalization of $53.61 billion, a P/E ratio of 23.97 and a beta of 1.07.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.07 earnings per share. Equities analysts forecast that Monsanto Company will post $5.70 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.77%. Monsanto’s payout ratio is presently 42.27%.

A number of equities analysts have recently issued reports on MON shares. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a research note on Wednesday, July 12th. Wells Fargo & Company increased their target price on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research note on Tuesday, October 10th. UBS AG downgraded Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price for the company. in a research note on Friday, August 18th. Finally, BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Eleven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $124.61.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply